Latest Governance Changes News

PYC Therapeutics reported a narrowed half-year loss of $22.8 million while progressing four RNA drug candidates through clinical stages. The company announced a major $653 million capital raising to extend its cash runway to 2030 and support ongoing development.

L1 Global Long Short Fund Limited reports a remarkable half-year turnaround with a 609% jump in net profit, driven by a new investment manager and a refreshed strategy. The company also declares a fully franked interim dividend as it completes a major equity raise and portfolio transition.

BSA Limited reported an 84% plunge in revenue for the half-year ending December 2025, driven by lost contracts and reduced volumes, yet managed a $6.3 million profit amid restructuring and cost controls. Significant board changes signal a strategic reset as the company navigates uncertain waters.

Telix Pharmaceuticals delivered a strong 56% revenue increase in 2025, driven by U.S. sales of Illuccix and the launch of Gozellix, while advancing its therapeutic pipeline and expanding global manufacturing capabilities. Despite a net loss, the company is investing heavily in R&D and sustainability initiatives aligned with climate-related disclosures.

Rhythm Biosciences reported a $2.26 million half-year loss as it advances ColoSTAT into commercialisation and expands geneType partnerships, signalling a pivotal phase for the ASX-listed medical diagnostics company.

Cycliq Group Limited reported a 27% revenue decline for the half-year ending December 2025 but managed to return to profitability amid strategic platform upgrades and steady customer engagement.

Perpetual Credit Income Trust reported a robust half-year performance with a 50% jump in net assets to $802 million and an 8% rise in profit to $21 million, underpinned by a successful capital raising and steady distributions.

Taiton Resources has completed drilling at its Challenger West project and is preparing to drill at the Highway project's Yogi prospect, backed by a $2 million capital raise and a key board appointment.

TrivarX Limited has expanded its diagnostic portfolio by acquiring the Stabl-Im brain cancer imaging technology and reported strong clinical trial results validating its single-lead ECG algorithm for depression screening in US veterans.

Archer Materials has made significant strides in its quantum computing and medical diagnostics programs, including improved carbon qubit readout and clinical-standard silicon biochips, while securing key partnerships and maintaining a strong cash position.

Otto Energy reported stable oil and gas production for the December quarter, supported by a strong cash position and strategic board changes. Despite a dip in oil prices, the company’s focus on cash flow and cost management positions it well for the year ahead.

Ioneer Ltd has reported a significant uplift in the economics of its Rhyolite Ridge lithium-boron project, alongside ongoing strategic partnership talks and strong market demand for lithium and boric acid.